|
Name |
Type |
Discontinued? |
|
1 |
RESULT_ID |
VARCHAR |
No |
|
|
|
The unique identifier for the result record. |
|
|
2 |
CAP_COMMENTS |
VARCHAR |
No |
|
|
|
CAP synoptic form item: General comments. |
|
|
3 |
SPEC_INTEGRITY_C_NAME |
VARCHAR |
No |
|
|
|
CAP synoptic form item: Specimen Integrity. |
May contain organization-specific values: Yes |
Category Entries: |
Intact |
Fragmented |
Single intact specimen (margins can be evaluated) |
Multiple designated specimens (e.g., main excision and identified margins) |
Fragmented (margins cannot be evaluated with certainty) |
Morcellated hysterectomy specimen |
Intact hysterectomy specimen |
Disrupted |
Indeterminate |
Other |
Not specified |
|
|
4 |
SPECIMEN_WEIGHT |
NUMERIC |
No |
|
|
|
CAP synoptic form item: Specimen Weight. |
|
|
5 |
SPEC_PROC_SPECIFY |
VARCHAR |
No |
|
|
|
CAP synoptic form item: Specify the Specimen Procedure. |
|
|
6 |
TUMOR_SIZE_GREAT |
NUMERIC |
No |
|
|
|
CAP synoptic form item: Tumor Greatest Size. |
|
|
7 |
TUMOR_SIZE_ADDL |
NUMERIC |
No |
|
|
|
CAP synoptic form item: Tumor Size (length). |
|
|
8 |
TUMOR_SIZE_ADDL2 |
NUMERIC |
No |
|
|
|
CAP synoptic form item: Tumor Size (width). |
|
|
9 |
TUMOR_SIZE_SPECIFY |
VARCHAR |
No |
|
|
|
CAP synoptic form item: Specify Tumor Size. |
|
|
10 |
HISTO_TYPE_SPECIFY |
VARCHAR |
No |
|
|
|
CAP synoptic form item: Specify histologic type. |
|
|
11 |
DIST_FROM_MARGIN |
NUMERIC |
No |
|
|
|
CAP synoptic form item: Distance From Closest Margin. |
|
|
12 |
TREATMENT_EFFECT_C_NAME |
VARCHAR |
No |
|
|
|
CAP synoptic form item: Treatment Effect. |
May contain organization-specific values: Yes |
Category Entries: |
Not identified |
No prior treatment |
Not applicable |
Present |
No definite response identified (grade 3, poor/no response; extensive residual tumor) |
No definite response identified (grade 3, poor or no response) |
Greater than 10% residual viable tumor |
Less than 10% residual viable tumor |
Greater than 50% residual viable tumor |
Less than 50% residual viable tumor |
No definite or minimal response identified (poor or no response) |
Marked response (minimal residual cancer) |
No known presurgical therapy |
No definite response to presurgical therapy |
Probable or definite response to presurgical therapy |
Cannot be determined |
Indeterminate |
Not known |
|
|
13 |
VIABLE_TMR_PERCENT |
NUMERIC |
No |
|
|
|
CAP synoptic form item: Residual Viable Tumor Percentage. |
|
|
14 |
SPECIMEN_OTHER_SPFY |
VARCHAR |
No |
|
|
|
CAP synoptic form item: Specify other specimen. |
|
|
15 |
DISTNT_METASTASIS_C_NAME |
VARCHAR |
No |
|
|
|
CAP synoptic form item: Distant Metastasis. |
May contain organization-specific values: Yes |
Category Entries: |
Not applicable |
cM0 (i+): No clinical or radiographic evidence of distant metastasis |
pM0: No distant metastasis |
pM1: Distant metastasis |
pM1a: Intraperitoneal metastasis beyond the right lower quadrant, including pseudomyx |
pM1b: Nonperitoneal metastasis |
pM1: Distant detectable metastasis as determined by classic clinical |
pM1 (IVB): Distant metastasis |
pM1a: Separate tumor nodule(s) in contralateral lung; tumor with pleural nodules or |
pM1b: Distant metastases outside the lung / pleura |
pM1: Distant metastasis (documented in this specimen) |
pM1a: Metastasis in skin, subcutaneous tissues, or distant lymph nodes |
pM1b: Metastasis to lung |
pM1c: Metastasis to all other visceral sites or distant metastasis at any site |
pM1a: Nonregional lymph node(s) |
pM1b: Bone(s) |
pM1c: Other site(s) with or without bone disease |
pM1: Metastasis to sites other than CNS |
pM1a: Single lesion |
pM1b: Multiple lesions |
pM1c: CNS metastasis |
pM1d: Discrete mass(es) without leptomeningeal and / or CSF involvement |
pM1e: Leptomeningeal and / or CSF involvement |
pM1a: Non-regional lymph nodes or pulmonary metastasis |
pM1b: Distant metastasis other than to nonregional lymph nodes and lungs |
pM1a (III): Tumor extends to the lungs with or without genital tract involvement |
pM1b (IV): Tumor involves other metastatic sites |
pM1a: Largest diameter of the largest metastasis 3 cm or less |
pM1b: Largest diameter of the largest metastasis 3.1-8.0 cm |
pM1c: Largest diameter of the largest metastasis 8 cm or more |
pM1a: Lung |
pM1b: Metastasis involving distant sites other than lung (including skip metastases) |
Distant Metastasis present (includes metastasis to lymph nodes) |
|
|
16 |
DSTNT_METASTATIS_ST |
VARCHAR |
No |
|
|
|
CAP synoptic form item: Distant Metastatis Sites. |
|
|
17 |
ADDL_PATH_FIND_SPFY |
VARCHAR |
No |
|
|
|
CAP synoptic form item: Specify additional pathologic findings. |
|
|
18 |
TMR_EXTENSION_SPFY |
VARCHAR |
No |
|
|
|
CAP synoptic form item: Specify Tumor Extension. |
|
|
19 |
MRG_IVLV_TM_SPEC |
VARCHAR |
No |
|
|
|
CAP synoptic form item: Specify site for Margins Involved by Tumor. |
|
|
20 |
STAGE_THYMOMA_C_NAME |
VARCHAR |
No |
|
|
|
CAP synoptic form item: Stage Thymoma. |
May contain organization-specific values: Yes |
Category Entries: |
Thymoma |
Thymic carcinoma |
|
|
21 |
PATH_STAGE_THYM_C_NAME |
VARCHAR |
No |
|
|
|
CAP synoptic form item: Pathologic Staging for Thymomas (Modified Masaoka Stage). |
May contain organization-specific values: Yes |
Category Entries: |
Stage I: Grossly and microscopically encapsulated |
Stage IIa: Microscopic transcapsular invasion |
Stage IIb: Macroscopic capsular invasion |
Stage III: Macroscopic invasion of neighboring organs |
Stage IVa: Pleural or pericardial dissemination |
Stage IVb: Hematogenous or lymphatic dissemination |
Cannot be determined |
|
|
22 |
IMP_DIST_META_C_NAME |
VARCHAR |
No |
|
|
|
CAP synoptic form item: Implants / Distant Metastasis. |
May contain organization-specific values: Yes |
Category Entries: |
Cannot be assessed |
Not identified |
Present |
|
|
23 |
IMP_DIST_SITE_OTH |
VARCHAR |
No |
|
|
|
CAP synoptic form item: Implants / Distant Metastasis Present - Specify Other. |
|
|
24 |
IMMUNO_STAINS_SPFY |
VARCHAR |
No |
|
|
|
CAP synoptic form item: Specify Immunohistochemical Stains. |
|
|
25 |
LYMPH_ND_NUM_XMD |
NUMERIC |
No |
|
|
|
CAP synoptic form item: Specify the number of lymph nodes examined. |
|
|
26 |
LYM_ND_NUM_IVLV |
NUMERIC |
No |
|
|
|
CAP synoptic form item: Specify number of lymph nodes involved. |
|
|
27 |
LYMP_NODE_NON_PN_C_NAME |
VARCHAR |
No |
|
|
|
CAP synoptic form item: Lymph Nodes category when not using Regional Lymph Nodes (pN) notation. |
May contain organization-specific values: Yes |
Category Entries: |
Cannot be assessed |
No regional lymph node metastases |
Regional lymph node metastasis |
|
|
28 |
PT_THYMIC_CARC_C_NAME |
VARCHAR |
No |
|
|
|
CAP synoptic form item: Primary Tumor (pT) for Thymic Carcinomas. |
May contain organization-specific values: Yes |
Category Entries: |
pTX: Primary tumor cannot be assessed |
pT0: No evidence of primary tumor |
pT1: Tumor completely encapsulated |
pT2: Tumor invades pericapsular connective tissue |
pT3: Tumor invades neighbors, such as pericardium, mediastinal pleura, thoracic wall |
pT4: Tumor with pleural or pericardial dissemination |
|
|
29 |
REG_LYM_THYM_CARC_C_NAME |
VARCHAR |
No |
|
|
|
CAP synoptic form item: Regional Lymph Nodes (pN) for Thymic Carcinomas. |
May contain organization-specific values: Yes |
Category Entries: |
pNX: Regional lymph nodes cannot be assessed |
pN0: No regional lymph node metastases |
pN1: Metastasis in anterior mediastinal lymph nodes |
pN2: Metastasis in other intrathoracic lymph nodes excluding ant mediastinal lym node |
pN3: Metastasis in scalene and / or supraclavicular lymph nodes |
|
|
30 |
HIST_TYP_THYM_OTHER |
VARCHAR |
No |
|
|
|
CAP synoptic form item: Histologic Type - Specify Thymoma. |
|
|
31 |
HIST_TYP_THYMIC_OTH |
VARCHAR |
No |
|
|
|
CAP synoptic form item: Histologic Type - Specify Thymic carcinoma. |
|
|
32 |
TUMOR_EXT_LUNG_SPFY |
VARCHAR |
No |
|
|
|
CAP synoptic form item: Tumor Extension - Specify Lobes of Lung. |
|
|
33 |
TUMOR_EXT_PLEURA |
VARCHAR |
No |
|
|
|
CAP synoptic form item: Tumor Extension - Specify Pleura Location. |
|
|